Head of Governance & Predictive Quality Parma, Dublin or locations in , IT 25 nov. 2025 6259

Site Program Lead Milano, IT 1 nov. 2025 5979

Head of Validation and compliance Milano, IT 25 nov. 2025 5963

Medical Science Liaison - Rare Diseases Melbourne, AU 5 nov. 2025 6210

Head of Field Force AIR NorthWest, Spain madrid, ES 27 nov. 2025 6197

Primary Care Tıbbi Tanıtım Temsilcisi (Eskişehir) İstanbul, TR 28 nov. 2025 6325

National Account Director, Market Access - AIR US, Central Illinois, US 10 nov. 2025 6249

Global Medical Affairs Manager, AIR - Marketed Products HQ or Affiliates in Europe, IT 20 nov. 2025 5928

TX Expert / Hospital / Special Care Representative (all genders) Hamburg / Hannover, DE 6 nov. 2025 6236

National Account Director, Market Access - AIR US, Southeast Georgia, US 10 nov. 2025 6251

Senior Director, Global Patient Safety Science Everywhere in Europe, IT 22 nov. 2025 6078

Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 21 nov. 2025 6111

R&D Senior Product Owner Data Governance and Semantics Europe - remote, IT 2 nov. 2025 5985

R&D Senior Scientific Data Architect and Product Owner Europe - remote, IT 2 nov. 2025 5986

Clinical Program Leader Europe - Remote, IT 7 nov. 2025 5902

Clinical Program Leader, R&D Global Rare Diseases Europe - remote, GB 5 nov. 2025 6146

Translational and Precision Medicine Lead Europe - remote, GB 13 nov. 2025 6152

CMC Technical Leader Europe - remote / US - remote, IT 4 nov. 2025 6137

Sr. Medical Science Liaison, Global Rare Diseases - Hematology & Immunology (East Coast) East Coast, USA, US 18 nov. 2025 6182

Launch Excellence Lead, AIR Chiesi Offices in Europe, IT 3 nov. 2025 5886

Lead, HCP Marketer Cary, NC, US 6 nov. 2025 5667

Real World Evidence, Contractor Cary, NC, US 6 nov. 2025 6150

Thought Leader Liaison, PAH / PH-ILD Cary, NC, US 8 nov. 2025 6156

Sr. Director, Medical Affairs - PAH / PH-ILD, US Cary, NC, US 12 nov. 2025 6132

Lead Finance Business Partner, AIR, US Cary, NC, US 14 nov. 2025 6271